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Primary small cell neuroendocrine carcinoma of vagina is an extremely rare disease. There have been only 26 previously reported
casesinliterature.Here,wereportacaseofprimarysmallcellneuroendocrinecarcinomaofvagina.Immunohistochemistry(IHC)
showed tumor cells positive for synaptophysin, chromogranin, and neuron-speciﬁc enolase (NSE).
1.Introduction
Only ﬁve percent of small cell carcinomas arise in extra
pulmonary sites [1], accounting for one to two percent of
gynecological malignancies [1, 2] .T h e s et u m o r sh a v eb e e n
reported to originate in the cervix, endometrium, ovary,
vagina, and vulva in decreasing frequency [1, 3, 4]. Primary
smallcellneuroendocrinecarcinomasofvaginaarerare,only
26 cases have been reported in English literature [1]. They
have histological, ultrastructural, and immunohistochemical
features similar to small cell carcinoma reported elsewhere
in the body and in female genital tract [1, 3–5]. They have an
aggressive clinical behavior and a very poor prognosis even
with current therapeutic modalities [3–5].
2. Case History
Fifty-year-old woman was admitted to hospital with com-
plains of diﬃculty in urination and feeling of lump in ante-
riorpartofvaginasincelastsixmonths.Therewasnosigniﬁ-
cant past history and family history. Physical examination of
external genitalia shows urethral carbuncle. On per vaginal
examination, ﬁrm to hard mass was felt in the anterior
vaginal wall. There was no evidence of ulceration, bleeding,
discharge, or side wall involvement by tumor. On per spec-
ulum examination, cervix was normal. On transvaginal
sonography,massmeasuring1.5×1cmarisingfromanterior
vaginal wall was detected. Chest X-ray and ultrasonography
of the abdomen and pelvis were normal. The patient
underwent lump resection, and specimen was submitted
for histopathology examination. We received single greyish
white globular mass measuring 1.8 × 1.8cm. Cut section
was homogenous greyish white without any areas of hem-
orrhage or necrosis (Figure 1). On microscopic examination,
section shows diﬀuse inﬁltration of small darkly stained cells
arranged in ill-deﬁned nest and trabeculae (Figure 2). The
cells show ﬁne granular powdery chromatin, inconspicuous
nucleoli, and very scanty cytoplasm (Figure 3). Immunohis-
tochemistry conﬁrmed neuroendocrine origin by positivity
for synaptophysin (Figure 4), chromogranin (Figure 5), and
neuron-speciﬁc enolase (NSE) (Figure 6).
3. Discussion
Primary small cell neuroendocrine carcinoma of the lower
genital tract of the female was ﬁrst documented in 1972
by Albores-Saavedra et al. and diagnosed as carcinoid of
the uterine cervix [5, 6]. Primary small cell neuroendocrine
carcinoma of the vagina, ﬁrst reported in 1984 by Scully
et al., is a rare neoplasm with only 26 reported cases in
English literature to date [1, 4, 6]. Occurrence of this tumor
is common in postmenopausal females [2]. These lesions
have propensity for early, widespread dissemination [3].
Regardless of the extent of disease at present, most patients2 Pathology Research International
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die due to distant metastasis [1, 3]. There was no association
between survival and involvement of a particular vaginal
segment or amount of vaginal structure involved with tumor
[2]. The tumor can be accepted to be of neuroendocrine
character when presence of neuroendocrine granules can
be demonstrated on ultrastructural examination or tissue
expressionofatleasttwoneuroendocrinemarkersotherthan
neuron-speciﬁcenolase(NSE)isdetected[7].Synaptophysin
and chromogranin are the principle markers for neuroen-
docrine tumors [8].
In our case, the patient is 50-year-old postmenopausal
female, which is clinicopathologically correlated. Histologi-
calﬁndingsinourpatientareidenticaltothoseofpulmonary
small cell carcinoma. On the immunohistochemistry (IHC),
cytoplasm of tumor cells stained forsynaptophysin, chromo-
granin, and NSE. All these are markers for neuroendocrine
tumors [7, 8].
Allthoughextrapulmonarysmallcellcarcinoma(includ-
ing genital tract) is recognized as a clinicopathologic entity
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distinct from small cell carcinoma of lung, the aggressive
nature of these tumors is similar to that of the pulmonary
counterpart [1, 6]. Current diagnosis of neuroendocrine
tumors is signiﬁcantly improved by the introduction of the
chromogranin A (CgA) assay in plasma or serum as a tumor
marker, and by the use of somatostatin receptor scintigraphy
(SRS) for tumor localization. The SRS proved to be more
sensitive than CgA, with equivalent speciﬁcity. The plasma
CgA level is related to tumor secretory activity [9].
To conclude, primary small cell neuroendocrine carci-
noma of vagina is a rare tumor with aggressive behavior and
poor prognosis. They exhibit morphological features similar
to those of neuroendocrine tumor of both gastrointestinal
tract and lung and express neuroendocrine markers. EarlyPathology Research International 3
diagnosis and multimodality therapy are recommended for
better survival.
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